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LaboratoryAbstract Introduction: Gold standard method for Mycobacterium tuberculosis identiﬁcation is
microbial culture, but this method can cause cross-contaminations. In the present study we aimed
to investigate possible cross-contaminations in two main tuberculosis laboratories in Northwest of
Iran.
Methods: One hundred and ﬁfty-six isolates from two central tuberculosis laboratories were
investigated by IS6110-RFLP and VNTR-ETR methods.
Results: 53 isolates were clustered in 18 clusters. 15 isolates were smear negative and single
culture positive among which four isolates were suspected to be contaminated and in two isolates
(1.28%) contaminations were conﬁrmed.
Conclusion: With this conﬁrmation clustered isolates reduced from 53 isolates to 49 isolates and
recent transmission rate of tuberculosis reduced to 21.2%. This study showed genotyping smear
negative and single culture positive isolates can prevent unnecessary treatments and for this purpose
VNTR-ETR is a suitable method.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
According to 2012World Health Organization (WHO) Report,
8.6 million new tuberculosis cases occurred worldwide and 1.3
million death caused by Mycobacterium tuberculosis, which
170,000 cases of death occurred by multidrug resistant
Mycobacterium tuberculosis (MDR-TB) [1]. For control and
curbing the tuberculosis, diagnosis and detection of infectedrculosis.
666 M. Asgharzadeh et al.patients are essential. Therefore, we have a high number of
suspected samples in diagnostic laboratories. The best method
for tuberculosis detection is the isolation of M. tuberculosis in
bacterial culture. But, because of long environmental survival
ofM. tuberculosis during sample collection, it can contaminate
samples which are collected simultaneously [2] and this leads to
a false positive report. Cross-contamination may occur during
simultaneous sample collection from patients or during sample
inoculation which creates aerosols [3]. When a sample is being
collected with positive smear samples in, there are several
microbial cultures with low bacterial growth at the same time
or physicians’ diagnosis other than tuberculosis. Hence, the
possibility of false positive report is high. Considering the
above mentioned reasons, we can consider possible cross-con-
tamination [4]. Laboratories are using different methods for
investigating cross-contamination of M. tuberculosis, but con-
ventional methods are not able to detect all contaminations.
Therefore, molecular typing methods are used for a deﬁnitive
diagnosis of cross-contamination [5]. Also, these methods are
being used for investigating diversity of isolates and control
of tuberculosis [6]. One of these methods is IS6110-restriction
fragment length polymorphism (RFLP) which is the gold stan-
dard method for DNA ﬁngerprinting and is based on number
and place of IS6110 fragments [7]. Copy numbers of IS6110
can differ from 0 to 25 [8], but IS6110-RFLPmethod is not suit-
able for isolates with less than 5 copy number and Variable
Number of Tandem Repeats-Exact Tandem Repeats (VNTR-
ETR) is using in these isolates [9]. In this study, we aimed to
investigate possible cross-contamination in central laboratories
of Northwest of Iran using IS6110-RFLP and ETR-VNTR, to
prevent possible false positive results and unnecessary treat-
ments and to evaluate quality of tuberculosis diagnosis.
Materials and methods
Sample collection
All isolates ofM. tuberculosis were collected from patients who
referred to central tuberculosis laboratories in Northwest of
Iran. The study population comprised all patients from whom
at least one sample was positive for M. tuberculosis by culture.
One hundred and ﬁfty-six isolates of M. tuberculosis were
collected from two central tuberculosis laboratories in
Northwest of Iran. The isolates have been identiﬁed as M.
tuberculosis by Ziehl–Neelsen staining and standard microbio-
logical tests, including production of niacin, catalase activity,
nitrate reduction, pigment production and growth rate on
Lowenstein–Jensen medium.
IS6110-RFLP
Extraction of DNA from M. tuberculosis isolates was
performed by lysozyme, SDS, Proteinase K and CTAB [10].
Brieﬂy, Extracted mycobacterial DNA was digested with Pvu
II enzyme (Cinnagen, Iran) and subjected to electrophoresis
and hybridized with a 245 bp polymerase chain reaction-
ampliﬁed probe directed against the right arm of IS6110.
After hybridization, the insertion sequences were visualized
with a colorimetric system, the DIG DNA labeling and detec-
tion kit (Roche, Germany) by following the manufacturers’
instruction. Pvu II digested genome DNA of M. tuberculosisreference strain Mt 14323 was used as an external marker in
each gel [8]. The IS6110 ﬁngerprinting patterns were compared
by visual examination. A cluster ofM. tuberculosis was deﬁned
as two or more isolates which exhibited the same number of
copies of the IS6110 fragment with identical molecular sizes
[4].
VNTR-ETR
For eleven isolates which had less than ﬁve copies of IS6110
bands, VNTR-ETR analysis were performed using primers
for the ETR-A, ETR-B, ETR-C, ETR-D and ETR-E as
described by Frothingham and Meeker-O’cornnell [9]. PCR
was performed in 20 ll volume containing 10–100 ng DNA,
0.5 lM speciﬁc primers, 1.5 mM MgCl2, 100 lM each
dNTP, 50 mM KCl, 20 mM Tris–Cl, pH 8.4 and 1.25 U
DNA polymerase (Cinnagen, Iran). PCR was done with initial
7 min denaturizing step at 94 C and ﬁnal 7 min extension step
at 72 C, 35 cycles of 45 s at 94 C denaturizing and annealing
temperature 50 s and 72 C for 65 s. Annealing temperature
was used as follows: 66, 68, 69, 63 for ETR-A, ETR-B,
ETR-C, ETR-D and ETR-E respectively. In all PCRs negative
controls consisted of the PCR components without DNA.
Fragment lengths were determined in comparison with
100 bp DNA ladder plus size marker (Fermentas, Lithuania).
Identiﬁcation of cross-contamination
Cases of laboratory cross-contamination were determined
according to the criteria described by Ruddy et al. [2]. All clus-
tered isolates with greater than four bands on IS6110-RFLP
typing or ETR clustered isolates with fewer than ﬁve bands
on IS6110-RFLP typing were selected for further study as pos-
sible cases of cross-contamination. If a sample had been found
to be smear negative a single positive culture was checked for
the date of processing. If the sample was processed on the same
day as another specimen with matching genotype, the possibil-
ity of laboratory cross-contamination was suspected.
Laboratory, clinical and epidemiological data of the suspected
samples were received. A strain was deﬁned as a presumed case
of cross-contamination if the clinical data of the patients were
not consistent with tuberculosis, alternative diagnosis had been
identiﬁed, and there were no known epidemiological connec-
tions among involved patients [11]. The identiﬁcation pathway
used to determine cases of cross contamination is illustrated in
Fig. 1.
Results
Using IS6110-RFLP and VNTR-ETR, 123 distinct patterns
were identiﬁed, including 18 clustered patterns and 103 unique
patterns. Fifty-three isolates (33.97%) were included in
clusters. Among 53 patients in the clusters, 15 patients had
smear negative and single positive culture. Among 15 smear
negative single positive cultures, 11 clusters were from
patients processed on another day from possible source of
contamination, so they were not considered possible cases of
cross-contamination (Fig. 1). Four clusters were suspected to
be from laboratory cross-contamination because each of them
shared the same RFLP and ETR proﬁle with one or more posi-
tive cultures processed in the laboratory on the same day. A
RFLP clustered isolates with >4 bands or 
ETR clustered isolates with <5 bands
NO Yes
103 53
Smear negative and single positive culture
NO Yes
38 15
Processed on the same day with matching genotype
NO Yes
11
4
Clinically and epidemiologically not consisted with TB and an 
alternative diagnosis confirmed as presumed cross-contamination
NO
2
Yes
2
presumed coss-contamination
Figure 1 Flowchart used to identify cases of cross-contamination.
Table 1 Analysis of presumed cases of laboratory cross-contamination.
Cases Clinical characteristics Anti-TB
therapy
No. of possible
source sample
Duration between submission of case
and possible source sample
Assessment conclusion
1 HIV positive with cough Yes 1 Same day Not clinically consistent and
epidemiologically
2 Cough, fever, dyspnea,
chest pain, weight loss
Yes 1 Same day Renal failure
TB Lab Cross contamination 667total of 4 cultures were suspected of being possible source of
contamination. After analysis of the clinical and epidemiologi-
cal data of the 4 cultures suspected of being contaminated, the
possibility of laboratory contamination could not be excluded
for two cultures, so these 2 cases (1.28%) were suspected to
being presumed cases of cross-contamination (Table 1).Discussion
False positive results are not rare in the identiﬁcation of M.
tuberculosis but most of them cannot be recognized. In some
laboratories staff can distinguish possible false positive results
by their experiences according to phenotypic methods, unusual
antibiogram pattern and low number of colonies in Agar med-
ium [12]. But molecular typing methods increased sensitivity of
methods for detecting cross-contaminations and these methods
were introduced for quality control of TB laboratories [4]. In
this study we used IS6110-RFLP and VNTR-ETR methods
for investigating possible cross-contamination. As presented
in Fig. 1, samples with the same patterns were suspected
for cross-contamination and ﬁnally in 1.28% of samples,cross-contamination was conﬁrmed. Previously reported rate
of cross-contaminations ranged from 65% to 0.1% of isolates.
In the same studies, rate of cross-contamination in
San-Francisco was 0.2% [13], in London 0.54% [2] California
2% [14], The Netherlands 2.4% [5], Almeria – Spain 18.8%
[4] and in Brazil 65.9% [3]. Signiﬁcant differences seen in
various studies are because of lack of standard method for
detecting laboratory mistakes and cross-contaminations.
Some studies like our study investigated samples processed in
the same day and clustered in the same cluster as possible
cross-contaminations [15] but some other studies considered
longer time period for same clustered samples as possible
cross-contamination. Also in regions with higher prevalence
of TB, which had several positive cases per day, possibility
of false positive results increased [13]. Laboratory staff experi-
ences and strict observations have direct effect on possibility of
cross contamination. Because present study was done for cen-
tral laboratories of TB, higher rate of cross-contamination can
be expected for county marginal labs.
In the present study, 2 cases of cross-contamination con-
ﬁrmed by genotyping, the ﬁrst case happened because of
wrong numbering of sample. The case was of a 33 year old
668 M. Asgharzadeh et al.man with positive HIV and the second case was of an 83 year
old male inpatient with renal failure, cough, dyspnea, chest
pain and weight loss, whose pleural ﬂuid was sent for evalua-
tion. Direct acid fast smear was negative and single culture for
M. tuberculosis was positive. Both patients received anti-TB
therapy because of a positive report instead of receiving pre-
ventive Isoniazid therapy. This false positive report caused
difﬁculties for their relatives and Police in the ﬁrst case.
False positive has several side effects, including delay and
wrong diagnosis of the patients, receiving toxic anti-TB ther-
apy especially if the sample is contaminated with MDR
tuberculosis, hospitalization, examinations and radiography,
care costs, special cleaning costs, time spent by medical staff.
This overall cause high costs for the health care system. Also
indirect costs like loss of working days and psychological
consequences for patients are expected [5]. Today, Molecular
epidemiology studies are based on genotype analysis of cul-
tured M. tuberculosis. In this method recent transmission can
be calculated by a number of clustered cases. False positive
results cause higher estimation of recent transmission [4].
This study reduced clustered samples from 53 cases to 49 cases
(from 33.97% to 31.41%) and recent transmission rate reduced
from 22.4% ((52–18)/156) to 21.2% ((49–16)/156). This shows
beneﬁt of molecular epidemiology studies for exact estimation
of recent transmissions and importance of molecular genotyp-
ing in single culture positive and smear negative samples.
Several factors can cause mistakes and result in false
positive reports including contamination of medical sampling
instruments including bronchoscope, nebulizer, wrong
numbering, technicians inexperience [16], lack of staff, defects
in conditioned biological cabinets, not well twisted UV light
because of crowded cabinets [17], contaminated pipettes,
loops, covers or decontamination solutions. But the main rea-
son of contamination is the creation of aerosols during several
microbial cultures in the same time [18]. On a working day
with several negative smears but positive culture or unusual
drug resistant patterns or inconsistent results of clinic and
lab are signs of possible false positive.
For preventing possible false positive results, providing
special questionnaire including personal information, history
of disease, clinical signs and time of examination is
needed to distinguish possible cross-contaminations. Enough
laboratory practice can reduce the contamination and increase
knowledge of staff. This can be done by regular training of TB
lab staff by specialists in this ﬁeld. Also good cooperation of
physicians and laboratories can be helpful for better result
consistency [19]. Also PPD test, chest radiography and history
of contact with TB patients can be helpful for detecting false
positive results.
This study showed that DNA ﬁngerprinting and Feedback
providing are important for preventing false positive results.
Marginal TB laboratories can send their samples with ade-
quate questionnaire to central labs for overall consideration
and genotyping. Central TB labs should report all possible
false positive results to marginal labs to prevent wrong treat-
ments and improving sampling and microbial culture methods.
Tuberculosis transmission recently has been increased in
Iran [1] and speciﬁc strains are coming to be prevalent due
to immigrations from neighbor countries [20]. Therefore, the
number of referred patients to TB labs has been increased
which causes higher possibility of cross-contamination, unless
we prevent contaminations and detect possible cases.Molecular epidemiology can help to monitor and control
TB. IS6110-RFLP is costly and time consuming and not suit-
able for samples with less than 5 copies of IS6110. VNTR-ETR
can be used as an initial evaluation of all smear negative and
single culture positive samples [19]. But conﬁrmation with
IS6110-RFLP is needed [21] or other techniques like mycobac-
terial interspersed repetitive unit (MIRU) [22] can be used for
detection of false positive cases. It should also be noted that
cost of genotyping is lower than false diagnosis [23].
Doubt on smear negative and single culture positive sample
for cross-contamination is important, however it should be
noted that in our study among 41 smear negative single culture
positive, just 2 samples were false positive. Therefore, low
colonies or negative smear cannot justify cross-contamination.
We did not investigate marginal laboratories and our
samples were collected from two central TB laboratories, but
fortunately all TB suspected samples in Northwest of Iran
were sent to these two TB labs.Conclusion
Our study showed the rate of cross-contamination in the inves-
tigated labs of Northwest of Iran was low but for preventing
any possible cross-contamination, VNTR-ETR should be used
as routine genotyping method.Recommendation
Major recommendations for preventing cross-contamination
are: (1) Aliquot decontamination solutions for daily usage;
(2) All culture positive isolates should be investigated by
genotyping methods; (3) Because there is no standard method
for detecting cross-contaminations, we recommend VNTR-
ETR as initial investigation.Conﬂict of Interest
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